Epigenetic Modification of CFTR in Head and Neck Cancer

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel crucial for epithelial function.
• CFTR dysfunction is linked to various pathologies, including cancer, but its role in head and neck cancer (HNC) is unexplored.
• CFTR is implicated as a tumor suppressor in intestinal, lung, and breast cancers.

Purpose of the Study:

• To investigate CFTR expression patterns and epigenetic modifications in HNC.
• To determine the functional impact of CFTR on cancer-related genes in HNC.

Main Methods:

• Analysis of CFTR expression in normal and HNC tissues and cells.
• Treatment with 5-aza-2'-deoxycytidine (5-Aza-CdR) to assess CFTR expression rescue.
• Patch clamp technique to confirm CFTR channel function.
• Analysis of CFTR CpG island methylation status.
• Assessment of CFTR's impact on apoptosis, proliferation, motility, and invasion.

Main Results:

• CFTR was expressed in normal tissues/cells but absent in HNC tissues/cells.
• 5-Aza-CdR treatment rescued CFTR expression and function.
• CFTR CpG islands were hypermethylated in HNC and hypomethylated in normal tissues/cells.
• CFTR silencing promoted proliferation, motility, and invasion while suppressing apoptosis in HNC.

Conclusions:

• Epigenetic modifications, specifically hypermethylation of CFTR CpG islands, are critical for CFTR down-regulation in HNC.
• CFTR deficiency is closely associated with HNC development and progression.
• Restoring CFTR expression and function may represent a therapeutic strategy for HNC.